SCHEMBL1940494

SCHEMBL1940494

COc1nn2c(Br)cccc2c1NC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 3/20 0.36
ALDH1A1 P00352 5/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 4/20 0.33
KDM4E B2RXH2 3/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
CYP1A2 P05177 2/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4033910 0.80 GAA (0.36) LMNAMAPTSMN1; SMN2GAAKDM4E
SCHEMBL1942487 0.74 CRHR1 (0.46) ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL3105608 0.73 CRHR1 (0.34) ALDH1A1GAANPC1RAB9A
SCHEMBL1942087 0.72 PDE4B (0.32) PDE4BGABRA1GABRG2GABRB3GABRA5
SCHEMBL1942766 0.71 PDE4B (0.32) PDE4BKMT2AHTT
SCHEMBL4040564 0.71 LCK (0.42) LMNASMN1; SMN2GAAKMT2ANPC1
SCHEMBL4032290 0.68 BRD4 (0.36) GAAKMT2ANPC1RAB9AMEN1
SCHEMBL27228493 0.67 MAPT (0.34) ALDH1A1LMNAMAPTSMN1; SMN2KDM4E
SCHEMBL4032749 0.66 ATR (0.37) PDE4BGAAKMT2ANPC1RAB9A
SCHEMBL31277480 0.64 ALDH1A1 (0.53) ALDH1A1LMNAMAPTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389618-B1 PYRAZOLO 1,5-A PYRIDINES AND MEDICINES CONTAINING THE SAME EISAI R&D MAN CO LTD (JP) 2011-06-15 EP disclosed
US-7625925-B2 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD (JP) 2009-12-01 US disclosed
EP-1555265-B1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS EISAI R&D MAN CO LTD (JP) 2009-03-25 EP disclosed
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS HIBI SHIGEKI 2008-03-27 US disclosed
US-7323569-B2 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-01-29 US disclosed
US-20070249663-A1 PYRAZOLO[1,5-a]PYRIDINES AND MEDICINES CONTAINING THE SAME HIBI SHIGEKI 2007-10-25 US disclosed
US-7285666-B2 Pyrazolo[1,5-a] pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-10-23 US disclosed
US-7176216-B2 7-phenylpyrazolopyridine compounds EISAI CO., LTD. (JP) 2007-02-13 US disclosed
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds EISAI CO.LTD. (JP) 2006-10-19 US disclosed
US-20060217348-A1 Pyrazolo[1,5-a] pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-09-28 US disclosed
US-7091215-B2 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI CO., LTD. (JP) 2006-08-15 US disclosed
EP-1555265-A1 7-PHENYL PYRAZOLOPYRIDINE COMPOUNDS Eisai Co., Ltd. (JP) 2005-07-20 EP disclosed
US-20040224974-A1 7-phenylpyrazolopyridine compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-11-11 US disclosed
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-06-24 US disclosed
EP-1389618-A1 PYRAZOLO 1,5-A]PYRIDINES AND MEDICINES CONTAINING THE SAME Eisai Co., Ltd. (JP) 2004-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249663-A1 PYRAZOLO[1,5-a]PYRIDINES AND MEDICINES CONTAINING THE SAME NR3C1, NR3C2, NR5A2 PDE4B 1362/4885ALDH1A1 2022/4885LMNA 2983/4885
US-20040224974-A1 7-phenylpyrazolopyridine compounds CRHR1, MC2R, CRH PDE4B 704/4885ALDH1A1 2616/4885LMNA 4734/4885
US-20080076943-A1 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS MC2R, CRHR1, CRHR2 PDE4B 704/4885ALDH1A1 3348/4885LMNA 4727/4885
US-20040122039-A1 Pyrazolo[1,5-a]pyridines and medicines containing the same XDH, NR3C1, NR5A1 PDE4B 1417/4885ALDH1A1 1142/4885LMNA 2972/4885
US-20060235011-A1 7-Phenyl pyrazolopyridine compounds MC2R, CRHR1, CRHR2 PDE4B 763/4885ALDH1A1 3334/4885LMNA 4718/4885
US-20060217348-A1 Pyrazolo[1,5-a] pyridines and medicines containing the same NR3C1, NR3C2, NR5A2 PDE4B 1362/4885ALDH1A1 2022/4885LMNA 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.